Activity in this selectionUnited States · Aug 31, 2026 · Aug 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $77M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionInduProDevelops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease
Role not disclosed